Get startedLog in
    Picture of Basilea Pharmaceutica AG, Allschwil logo

    BSLN — Basilea Pharmaceutica AG, Allschwil News Story

    0.000.00%
    ch flag iconLast trade - 00:00
    HealthcareAdventurousMid CapHigh Flyer
    All News

    Brief: Basilea Receives USD 25 Million Funding Under Barda Agreement To Continue To Advance Novel Antifungals Fosmanogepix And Bal2062

    Picture of Basilea Pharmaceutica AG, Allschwil logoBasilea Pharmaceutica AG, Allschwil
    16/09/2025 06:19
    Sept 16 (Reuters) - BASILEA PHARMACEUTICA AG ALLSCHWIL BSLN.S:

RECEIVES USD 25 MILLION FUNDING UNDER BARDA AGREEMENT TO CONTINUE TO ADVANCE NOVEL ANTIFUNGALS FOSMANOGEPIX AND BAL2062

Source text: ID:nGNX7KMQGy

Further company coverage: BSLN.S

 (Gdansk Newsroom)

 ((((gdansk.newsroom@thomsonreuters.com ; +48 587785269; ));))

    Recent news on Basilea Pharmaceutica AG, Allschwil

    See all news